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Genomic selection in multi-environment crop trials
Abstract
Genomic selection in crop breeding introduces modeling challenges not found in animal studies. These
include the need to accommodate replicate plants for each line, consider spatial variation in field trials,
address line by environment interactions, and capture nonadditive effects. Here, we propose a flexible
single-stage genomic selection approach that resolves these issues. Our linear mixed model incorporates
spatial variation through environment-specific terms, and also randomization-based design terms. It
considers marker, and marker by environment interactions using ridge regression best linear unbiased
prediction to extend genomic selection to multiple environments. Since the approach uses the raw data
from line replicates, the line genetic variation is partitioned into marker and nonmarker residual genetic
variation (i.e., additive and nonadditive effects). This results in a more precise estimate of marker genetic
effects. Using barley height data from trials, in 2 different years, of up to 477 cultivars, we demonstrate
that our new genomic selection model improves predictions compared to current models. Analyzing
single trials revealed improvements in predictive ability of up to 5.7%. For the multiple environment trial
(MET) model, combining both year trials improved predictive ability up to 11.4% compared to a single
environment analysis. Benefits were significant even when fewer markers were used. Compared to a
single-year standard model run with 3490 markers, our partitioned MET model achieved the same
predictive ability using between 500 and 1000 markers depending on the trial. Our approach can be used
to increase accuracy and confidence in the selection of the best lines for breeding and/or, to reduce costs
by using fewer markers.
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GENOMIC SELECTION

Genomic Selection in Multi-environment Crop Trials
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and Robbie Waugh*,**,3
*Division of Plant Sciences, School of Life Sciences, University of Dundee at The James Hutton Institute, and
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ABSTRACT Genomic selection in crop breeding introduces modeling challenges not found in animal
studies. These include the need to accommodate replicate plants for each line, consider spatial variation in ﬁeld
trials, address line by environment interactions, and capture nonadditive effects. Here, we propose a ﬂexible
single-stage genomic selection approach that resolves these issues. Our linear mixed model incorporates
spatial variation through environment-speciﬁc terms, and also randomization-based design terms. It considers
marker, and marker by environment interactions using ridge regression best linear unbiased prediction to
extend genomic selection to multiple environments. Since the approach uses the raw data from line replicates,
the line genetic variation is partitioned into marker and nonmarker residual genetic variation (i.e., additive and
nonadditive effects). This results in a more precise estimate of marker genetic effects. Using barley height data
from trials, in 2 different years, of up to 477 cultivars, we demonstrate that our new genomic selection model
improves predictions compared to current models. Analyzing single trials revealed improvements in predictive
ability of up to 5.7%. For the multiple environment trial (MET) model, combining both year trials improved
predictive ability up to 11.4% compared to a single environment analysis. Beneﬁts were signiﬁcant even when
fewer markers were used. Compared to a single-year standard model run with 3490 markers, our partitioned
MET model achieved the same predictive ability using between 500 and 1000 markers depending on the trial.
Our approach can be used to increase accuracy and conﬁdence in the selection of the best lines for breeding
and/or, to reduce costs by using fewer markers.

Whole genome prediction (WGP) uses genotypic information in the
form of molecular genetic markers to predict individual phenotypic
performance, and has utility in livestock and crop breeding. For a
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particular population, WGP associates a phenotypic value with each
molecular marker allele, which is consequently known as a marker effect.
The sum of the marker effects (which relate to the alleles present in an
individual’s genotype) is a predictor of their phenotypic performance,
and is known as a genomic estimated breeding value (GEBV). In ‘Genomic Selection’ (GS), the GEBV is used to select the best parents for
breeding, or to predict the performance of progeny using only genotyping data without the need for phenotypic screening. In order to derive
GEBVs for prediction, an initial ‘training population’ is phenotyped
and genotyped to estimate marker effects. GEBVs can then be calculated for individuals descended from, or related to, the training population (a ‘validation population’) that have not been phenotyped, but
for which genotypic information is available. This saves both time and
the costs associated with phenotyping in a breeding program. Since GS
uses all genetic markers to calculate the GEBV, it potentially captures all
of the loci that inﬂuence a trait. This distinguishes GS from more
traditional marker assisted selection (MAS), where a few diagnostic
markers are used to follow the inheritance of speciﬁc loci inﬂuencing
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a trait, and marker assisted recurrent selection (MARS), where only a
subset of signiﬁcant markers are used to select for quantitative trait loci
(QTL) in a given population. The potential of GS to accelerate crop
improvement due to shorter generation times and the avoidance of
phenotypic evaluation has been established (Jannink et al. 2010), and
shown to outperform MAS (Heffner et al. 2010) and MARS (Massman
et al. 2013).
Since 2001, when Meuwissen et al. (2001) compared least square,
ridge regression best linear unbiased prediction (RR-BLUP) and two
Bayesian approaches (BayesA and BayesB) for GS in animal breeding,
there has been an increase in the number of methods available (Wang
et al. 2012; de los Campos et al. 2013; Desta and Ortiz 2014), and
widespread uptake, particularly in dairy cattle breeding, where ofﬁcial
GEBVs are published (http://www.interbull.org). These GS methods,
however, differ in their predictive ability (de los Campos et al. 2013)
and suitability for speciﬁc applications. Crop populations may require
different GS methods to those of animals due to the potential presence
of extensive linkage disequilibrium (LD), population substructure, and
agronomic performance traits which are often inﬂuenced by many
QTL of small effect (Wimmer et al. 2013). In a simulated data set based
on actual marker data from barley, RR-BLUP was found to be more
accurate than BayesB (Zhong et al. 2009), and has been recommended
for crop improvement applications (Heslot et al. 2012). Wimmer et al.
(2013) compared the performance of four commonly used methods;
RR-BLUP and BayesB (Meuwissen et al. 2001), LASSO (Tibshirani
1996), and the elastic net (Zou and Hastie 2005). They also found good
performance with RR-BLUP, and recommended its use in crops. RRBLUP has the advantage over Bayesian approaches of being easily
implemented and quick.
Despite these advances, GS is only starting to be adopted in crop
breeding. Some of the reluctance to adopt GS may be due to the
additional modeling challenges of crop improvement scenarios. Suitable
models need to accommodate data from replicate plants of the same line,
the inﬂuence of spatial variation in the ﬁeld, and potentially different
‘environments’ if the crop is trialed in several locations or multiple
years. These variables introduce signiﬁcant genotype by environment
interactions (G · E) and new methods are needed that consider G · E
effects, as well as nonadditive effects, and the crop-speciﬁc (in)breeding
cycle (Jonas and De Koning 2013).
The reasons for considering spatial variation in crop breeding
activities are obvious. Every trial (or environment) will have considerable
sources of nongenetic variation such that even the position of a line in the
ﬁeld will impact its phenotypic response. Allowing for spatial variation
through appropriate trial design and analysis will ensure that more
accurate genetic effects are revealed (Gilmour et al. 1997). In GS, this is
also true; the accuracy of genomic prediction in RR-BLUP is improved
after adjusting for spatial variation using moving-means as a covariate
in the model (Lado et al. 2013).
Similarly, consideration should be paid to the fact that crop lines are
often assessed in a multi environment trial (MET), i.e., in different
geographic locations, seasons, or years, in order to determine performance stability across environments (i.e., G · E). In GS, G · E is an
important component of genetic variability (Crossa et al. 2010, 2011). A
MET in a GS context is therefore an important extension as it allows the
examination of marker by environment (M · E) interactions, and, in
particular, the identiﬁcation of markers whose effects are stable across
environments (trials), as well as those that are environment-speciﬁc. As
RR-BLUP involves ﬁtting a linear mixed model, the incorporation of a
MET extension is straightforward, and improvements in prediction
when using two stage approaches to MET analysis have already been
shown (Burgueno et al. 2012; Guo et al. 2013).
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Capturing nonadditive effects in genomic selection is more complicated because the genomic relationship matrix described by the markers
and used in RR-BLUP captures not only additive genetic relationships at
QTL but also LD and cosegregation information (Habier et al. 2013). A
ﬁrst step toward modeling nonadditive effects in GS is to include pedigree information that captures a polygenic effect. Pedigree information
included in a BayesB model in animal GS marginally improved the
accuracy of selection, and reduced bias, which is important when
marker effect estimates are used over multiple generations (Solberg
et al. 2009). A small improvement in crops has also been shown (Crossa
et al. 2010). Burgueno et al. (2012) explored the inclusion of pedigree
information in RR-BLUP MET models, and found that it improved
prediction accuracy for individual lines in some circumstances, but not
others. However, compared to use of pedigree, inclusion of both additive and nonadditive marker-based, or realized genomic relationship
matrices further improves prediction of breeding values (Munoz et al.
(2014).
Most methods of crop GS use a two-stage analysis. First, data from
individual replicated plants or plots are used to derive the line means.
This allows software already developed for animal studies, which cannot
handle replicates, to use the means for RR-BLUP in the second stage.
However, a two-stage approach biases marker effects, and induces
heterogeneous residual variances and residual correlations that are
not completely eliminated by a weighted analysis (de los Campos
et al. 2013). A single-stage approach that uses individual plant or plot
data, includes replication, and accounts for spatial variation and randomization-based terms (e.g., blocking factors), would be preferable
because it would not have the difﬁculties associated with a two-stage
approach. Incorporating data from individual plant or plot replicates
would have additional advantages for GS. Markers may not capture all
the genetic variation contributing to the phenotype, particularly if the
number of markers used for prediction is low. Including replicates
allows the total genetic effect due to lines to be partitioned into the
genetic effect due to markers, and a residual genetic effect not captured
by markers, which will include nonadditive genetic effects. This approach is possible without the need for pedigree information (which is
not always available), would be more encompassing than a polygenic
effect, and would not require the calculation of additional matrices that
can induce dependency between variance components. In addition,
separating out the nonadditive genetic effects from the model residual
variance should increase the accuracy and predictive ability of the
additive genetic effects compared to two-stage analyses.
In this paper, we propose such a single-stage approach to the analysis
of multi-environment data by ﬁtting a single linear mixed model that
extends single trial RR-BLUP analysis. Marker and M · E interactions
are incorporated as terms in the model, and form the basis for the
analysis of METs. In this GS approach, the marker and M · E interaction terms are assumed to be random using RR-BLUP, and the
approach extends RR-BLUP analysis by partitioning the term for genetic variation into marker and nonmarker (or residual genetic) variation using raw data from individual replicates, rather than line means.
We ﬁrst outline the proposed method that we refer to as partitioned
RR-BLUP for MET, and then illustrate its use on a real data set with
appropriate comparisons to nonpartitioned, or standard, models and
single trial RR-BLUP analysis, both within a single-stage approach.
MATERIALS AND METHODS
Description of motivating example
The new approach is illustrated with an example data set of the
phenotypic trait ‘height’ in an association mapping population of

cultivated barley. During two consecutive years (2010 and 2011; referred
to also as trials), spring barley lines were grown in pots, in the ﬁeld,
within a polythene tunnel, with each pot containing one plant (from one
line). In each trial, the pots were arranged in a spatial row-column design
with ﬁve replicate blocks, where the replicate blocks correspond to biological replicates. In the 2010 trial, 648 lines were planted with pots
arranged in 405 columns by eight rows, with each replicate block consisting of 81 columns by eight rows. In the 2011 trial, 856 lines were
planted with pots arranged in 535 columns by eight rows, with each
replicate block containing 107 columns (see Oakey et al. 2013 for further
details). There were 639 lines common to both trial years. The lines were
predominantly European elite cultivars of two-row spring barley. At full
maturity, the height of each plant was measured in centimeters from the
base of the plant to the top of the main stem. The software CycDesigN
4.0 (VSN International) was used to generate the design each trial year.
A set of 7864 high-conﬁdence, gene-based single nucleotide polymorphism (SNP) markers, incorporated into a single Illumina iSelect
assay (Illumina Inc.), was used to genotype DNA extracted from 477
lines (Comadran et al. 2012), including 459 lines grown across both
years, one line from 2010 only, and 17 lines from 2011 only. Nonpolymorphic SNPs, and SNPs with more than 20% missing values,
were removed. For each marker, individuals were coded as 0 (homozygous minor allele), or 2 (homozygous major allele). The population
consists of lines that are derived via single seed descent and should
be homozygous; a heterozygous marker within a particular individual
suggests that there is an error with the calling of the marker, thus these
heterozygous markers were coded as missing. Missing values were
imputed using the R package impute (Hastie et al. 2014). Markers that
were heterozygous and failed to converge to either 0 or 2 after several
iterations were discarded, because this suggests the marker itself may
not be appropriate for use. This resulted in a set of 4654 homozygous
markers with a minimum minor allele frequency of .5% and map
positions available for analysis. The ﬁnal set of 3490 markers used in
the analysis was a subset of the 4654 markers, and had no two markers
identical in terms of their qualitative coding across the lines. Pedigree
information on the lines was unavailable. The phenotypic and genotypic data are available in Supplemental Material, File S2.
General form of the new model for whole
genome prediction
A general form of the new model is now presented. This is a single linear
mixed model that incorporates marker and M · E interactions as
terms in the model with appropriate variance-covariance structures
to allow for correlation between trials. In this new approach, the genetic
variation is partitioned into marker and nonmarker (or residual) variation through the inclusion of all raw data in the model. In addition,
spatial trends and design and randomized factors can be easily incorporated in the model. The new model is referred to as the partitioned
RR-BLUP for MET. We use the term ‘trial’ to denote different environments, which for our example data set represents different years.
Consider a data set consisting of v lines and s trials. The new mixed
model for whole genome prediction can be developed as follows
y ¼ Xt þ Z g g þ Z u u þ e
where yðn · 1Þ ¼ ðyT1 ; . . . ; yTs ÞT

(1)

is the vector of response across

ðn · 1Þ

is the vector of response for trial t and
each of the s trials, yt t
s
P
n¼
nt , where nt is the number of observations (pots) in trial t,
t¼1

t is a vector of ﬁxed terms, consisting of an overall mean performance for each trial, as well as trial speciﬁc global or extraneous

spatial terms, for example, linear row or linear column effects, and
X is the associated design matrix, g ðvs · 1Þ is the vector of random line
effects of the v lines in each of the s trials with design matrix Z g , and
has the general form,
g ¼ ðI s 5MÞum þ ue

(2)

M is the (v · pÞ matrix of v lines by p SNP markers, I s is the (s · sÞ identity
ðps · 1Þ
matrix, um
is the vector of p random SNP marker effects in each of
ðvs · 1Þ
s trials and ue
is the vector of v random residual genetic effects in each
of s trials, and represents line variation (and therefore genetic variation) that
has not been accounted for by the markers; 5 is the kronecker product.
Let um take a general form
um ¼ Lm f m þ d m

(3)

· 1Þ
Where Lm is a (ps · pkÞ matrix, f ðpk
is a vector with
m
var( f m ) = Gm 5I p , where Gm is a (k · kÞ matrix for k factors,
ðps · 1Þ
dm
is a vector with varðdm ) = Cm 5Ip where Cm is the (s · sÞ
marker genetic variance matrix across trials.
Let ue also take a general form

ue ¼ Le f e þ de

(4)

· 1Þ
is a vector with
Where Le is (vs · vlÞ matrix, f ðvl
e
var( f e ) = Ge 5I v where Ge is a (l · lÞ matrix for l factors,
deðvs · 1Þ is a vector with varðde ) = Ce 5Iv where Ce is the (s · sÞ
residual genetic variance matrix across trials.
Thus with s trials, the genetic variance matrices Cm and Ce are both
sðs þ 1Þ
parameters to be estimated.
(s · sÞ matrices, each with
2
Let Lm ¼ Lm1 5Ip and Le ¼ Le1 5Iv , where Lm1 and Le1 are
(s · kÞ and (s · lÞ matrices of k and l factor loadings for each trial,
respectively
then



varðum Þ ¼ Lm1 Gm LTm1 þ Cm 5I p
and


varðue Þ ¼ Le1 Ge LTe1 þ Ce 5I v
ðb · 1Þ

The vector uðb · 1Þ consists of sub vectors ui i
, where the subvector
ui corresponds to the ith random term. The corresponding design
· 1Þ
matrix Z ðb
is partitioned conformably as ½Z u1 . . . Z ub . The subu
vectors are assumed mutually independent with variance u2i I bi . The
subvectors include random terms for describing spatial trends in individual trials, such as random row, random column, or spline terms.
The residual vector e has variance R ¼ 4st¼1 Rt , a block diagonal
matrix of s blocks, Rt ¼ u2t I nt .
In crops, the modeling of spatial trends in ﬁeld trials is crucial
(Gilmour et al. 1997), and the model above enables the addition of these
trends where necessary. Furthermore, trial-speciﬁc design or randomization-based terms such as blocking factors can also be included in the
model (Cullis et al. 2006).
Thus the line term g reﬂects the total genetic variation partitioned
into additive variation as described by the markers and residual genetic
or nonadditive variation, the ﬁxed t, random u and residual e terms
reﬂect the design and conduct of the trials, and as such provide the
underlying structure for nongenetic variation.
Special cases of the general form of g: The general form of g (Equation 2) shows the details for partitioning the total genetic variation.
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There are two special cases of g. A phenotypic model can be ﬁtted by
letting g ¼ ue , so that the um marker term is omitted, and g represents
total genetic variation (assuming unrelated lines) as described by the
phenotypic information. A standard RR-BLUP model for GS can be
ﬁtted by letting g ¼ ðI s 5MÞum , so that ue , the residual genetic term, is
omitted; here, g represents additive genetic variation as described by the
markers. The standard model reﬂects the most common current practice in GS, where only the markers are included in the model. These two
additional models will be used as comparators to the new partitioned
model.
Special cases of the general form of um : From the general form of um
(Equation 3), special cases of s, the number of trials, and k, the number
of factors, can be considered. By varying s, single and multiple environment trials are encompassed, and by varying k different structures
for the variance-covariance matrix of um can be considered (Table 1).
Varying k enables an appropriate form of the varðum Þ to be established
to describe the correlation structure between trials, and may vary
depending on the data set. A similar table of special cases of the
form of ue (Equation 4) can also be constructed if l ¼ k, e ¼ m and
v ¼ p.
ðp · 1Þ
ðp · 1Þ
For a single trial um
¼ dm
is a main marker term, with
2
varðum Þ ¼ um I p . Models for multiple environment trials are now
discussed.
The simplest model for more than one trial is the diagonal
ðsp · 1Þ
· 1Þ
(DIAG) model, where um
¼ dðsp
is a main marker term in
m
each of the trials. The varðum Þ ¼ Cm 5I p , where Cm has offdiagonals for all trials assumed zero. The DIAG model therefore
assumes a separate marker variance for each trial, and no marker
covariance between trials, and is equivalent to ﬁtting each trial
separately.
· 1Þ
In the compound symmetry (CS) model, f ðp
is a main term for
m
ðps · 1Þ
markers, and dm
is an interaction term for the markers and trials.
All trials have the same marker variance, and all pairs of trials have the
same marker covariance, so that the varðum Þ ¼ ðu2m J s þ Cm Þ5I p
where J s is (s · sÞ matrix of ones and Cm ¼ u2me I s .
ðp · 1Þ
For the Cullis et al. (1998) (CS+DIAG) model, f m
is a main
ðps · 1Þ
marker term, and dm
is a term for the interaction of the markers
and trials. This model assumes the same marker covariance for pairs of
trials, and a separate marker variance for each trial. Thus, the form of
varðum Þ is the same in the CS and (CS+DIAG) models; however, in the
latter, Cm ¼ 4st¼1 u2mt . In this model, the covariance between pairs of
trials is assumed to be not greater than the variance of the individual
trials.
An unstructured (US) model allows different marker variances and
ðsp · 1Þ
· 1Þ
covariances between trials, so that um
¼ dðsp
is an interaction
m
term of the markers and trials, and no main marker effect is ﬁtted.
The varðum Þ ¼ Cm 5I p , where Cm has diagonal elements that are
the marker variances for the individual trials, and off-diagonal element
that are the marker covariance between trials. As the number of trials
increases, the US model becomes over parameterized, making it difﬁcult to ﬁt.
Multiplicative models have been shown to work well in practice in
MET analysis (Smith et al. 2005), and are viable alternatives to the
unstructured model. In fact, Kelly et al. (2007) found that the factor
analytic model with k factors (FAk) of Smith et al. (2001) was preferred
over an unstructured model because it improved the predictive accuracy of the line empirical BLUPs.
In a GS situation, a factor analytic model with a main marker
term and k factors (FAMk) may be more appropriate than a FAk
model that excludes this term. This is because a main marker term
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represents QTL that are common and stable across trials (in the
absence of an interaction between trials and markers) and the
marker · trial term will give information on QTL that are trial
or environment speciﬁc.
Smith et al. (2001) showed that a FAMk model is equivalent to
a factor analytic model with (k+1) factors, where the ﬁrst set of
loadings are constrained to be equal. For a FAMk model, we
let f Tm ¼ ð f T0 ; f T Þ, where u0 ¼ um f 0 , with varðu0 Þ ¼ u2m I p , f ðsk · 1Þ
is a vector of line scores with varð f Þ ¼ I k 5I p , then
varðum Þ ¼ ðu2m J s þ Lf LTf þ Cm Þ5I p , where Lf is a (s · kÞ matrix
of loadings, and Cm is a diagonal matrix with the diagonal elements
referred to as speciﬁc variances. The approach of including a main
marker term is in contrast to a phenotypic model for estimating
genotypic values, where, in crop ﬁeld trials, the main line term is
usually excluded. Notice when k = 0, the FAM0 model is equivalent
to the CS+DIAG model. The special cases of the general form of um
shown in Table 1, can be ﬁtted in each of the three models, phenotypic, standard, and partitioned, which reﬂect different forms of
g (Equation 2).
Computational efﬁciency: If the number of markers exceeds the
number of individuals, we can ﬁt
ug ¼ ðI s 5MÞum
The analysis will now be dependent on the number of lines rather than
on the number of markers, and therefore will reduce the dimensionality of the model, making it more computationally efﬁcient (Stranden
and Garrick 2009).
The estimation of variance parameters is by residual maximum
likelihood (REML). Given estimates of the variance components, empirical best linear unbiased predictors (E-BLUPs) were obtained for
random terms from the mixed model equations as


21 
~m ¼ I s 5MT MM T
~g
u
u
(5)
~g is the vector of genomic breeding values in each trial.
where u
Here, we use MM T as in Piepho et al. (2012), where MM T represents a realized genomic relationship matrix. Meuwissen et al. (2001)
used MM T =p, where p is the number of marker (locations), and Habier
P
et al. (2007) used MM T =2 pq ð1 2 pq Þ, where pq is the allele freq

quency at marker locus q. Omission of the scalar term will not affect
the conclusions of the analysis.
If ðMM T Þ21 is of full rank, then



ug
MM T M
¼ Gf 5
var
um
Ip
MT
for Gf ¼ Lm1 Gm LTm1 þ Cm
Thus, if
ug ¼ ðI s 5MÞum ¼ ðI s 5MÞLm f m þ ðI s 5MÞdm ¼ uf þ ud
Then, the E-BLUPs obtained from the mixed model equations are


21 
~f
Lm ~f m ¼ I s 5M T MM T
u

(6)



 
~m ¼ I s 5M T MM T 21 u
~d
d

(7)

and

n Table 1 Summary of the special cases of the general form of um a
Model

Description

s

k

Single trial
DIAG
US
CS
CS+DIAG

Diagonal (s = 1)
Diagonal
Unstructured
Compound symmetry
CS+DIAG

1
s
s
s
s

0
0
0
1
1

FAMkc,d

Factor analytic (main effect)

s

kþ1

Gm

Lm1

1s
1s
½um 1s


Lf 

u2m
u2m
u2m
0

0
Ik

Cm

STY or MET

Reference

u2m

4st¼1 u2mt b
Cm
u2me I s
4st¼1 u2mt

STY
STY
MET
MET
MET

Patterson et al. (1977)
Cullis et al. (1998)

4st¼1 u2mt

MET

Smith et al. (2001)

STY, single trial year (note the DIAG model is equivalent to analyzing each trial year separately); MET, multi-environment trial.
a
A similar table could be constructed for ue with l ¼ k, e ¼ m and v ¼ p.
b
4 represents a kronecker sum, so that 4st¼1 u2mt results in a diagonal matrix with elements u2mt for the speciﬁc variance of trial t.
c ðs · kÞ
L
is a matrix of k factor loadings at each of the s trials.
d f
For FAMk let f Tm ¼ ð f T0 ; f T Þ where u0 ¼ um f 0 , varðu0 Þ ¼ u2m I p and varð f Þ ¼ Ik 5Ip .

If ðMM T Þ21 is of full rank, then
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For our data set, the number of markers exceeds the number of
individuals, therefore the standard and partitioned models were ﬁtted
using the computationally efﬁcient approach. All models were ﬁtted
in ASReml v3.0-1 (Butler et al. 2009) for R v3.2.0 (R Core Team 2015).
Instructions for completing all the analysis shown in the paper can be
found in File S1 along with supporting data (File S2) and R scripts
(File S3, File S4, File S5, File S6, File S7, File S8, File S9, File S10, File
S11, File S12, File S13, File S14, File S15, File S16, File S17, File S18,
and File S19).
Heritability
The calculation of the generalized heritability in complex linear mixed
models is not straightforward (Cullis et al. 2006). Here, the generalized
heritability for each trial is calculated from the phenotypic model
a
(where g ¼ ue ) as 1 2 2 where a is the average pairwise prediction
2ugt
error variance of line effects, and u2gt is the genetic variance of trial t
(Cullis et al. 2006). The R code for calculating the heritability is in File S19.
Cross-validation
Initially, the phenotypic, standard, and partitioned models were ﬁtted
using the full data set to enable the most appropriate MET form of um
(Table 1), the term representing marker or additive variation, and ue ,
the term representing nonadditive or residual genetic variance, to be
established for use in the cross-validation. A single trial analysis was
also investigated in the cross-validation represented by the DIAG form.
We generally denote the phenotypic, standard, and partitioned models
with speciﬁc forms of um as EFORM, SFORM, and PFORM, respectively
[where FORM is either DIAG, US, CS, CS+DIAG, or FAMk (Table 1)].
To establish which MET form of um is superior, and to undertake
initial comparisons between the three models, the Akaike information
criteria (AIC) (Akaike 1974), or log-likelihood ratio test (if the models
were nested), were used. For example, the phenotypic and standard
model are nested within the partitioned model when the form of um
is the same, and can be compared using the log-likelihood ratio test.
However, models with different forms for um need to be compared
using the AIC. The AIC was calculated as twice the number of
random parameters minus twice the log-likelihood (the number of

ﬁxed parameters was ignored in this calculation as this was constant
over the models). For the AIC, lower values indicate superior models.
Once the form of um for the MET analyses has been established, the
cross-validations could proceed.
The cross-validation involved randomly dividing the lines in the data
set (as evenly as possible) into 10 groups, which were used across the
single and MET analyses so that consistency and comparability was
maintained as much as possible (Table 2).
Three different cross-validations were examined, and were deﬁned
by the number of groups in the validation and training sets. These were
CV10, CV20, and CV40, where approximately 10, 20, and 40% of lines,
respectively, were included in the validation set (Table 3), with the
remaining lines used as the training set. Iteration across all combinations was investigated. For example, for the CV20 cross-validation, two
groups (the validation set) were omitted in any one iteration. To cover
the possible combinations of two of the 10 groups, a total of 45 iterations were necessary. The R scripts with details of the random division
of the data and group combinations for CV10, CV20, and CV40 are in
File S3, File S4, and File S5, respectively.
Using the training set, marker effects were obtained under each model
(standard and partitioned), each cross-validation (CV10, CV20, and
CV40), and each scenario (single trial 2010, single trial 2011, and MET).
The marker effects (Equation 6 and Equation 7) were used to predict the
GEBVs of the lines in the validation set. The DIAG form of um and ue was
used to generate marker effects equivalent to analyzing each trial separately,
with each trial having one set of marker effects. For the MET analyses of
both trials, different forms of um and ue (Table 1) were initially investigated
as described previously, with the most appropriate forms used in the crossvalidation. For the CS, CS+DIAG, and FAM1 forms of um and ue , there
were three sets of marker effects. These were: the main marker effects,
representing markers that are stable across both trials, and marker effects
from each trial, which represent the additional marker by trial interaction.
A total marker effect for each trial was obtained by adding the main marker
effect to the marker by trial interaction effect. For completeness, the US
form, which produces only total marker effects for each trial, was also
initially investigated, although, as we are interested in MET models with
main marker effects, the cross-validation focused on the most appropriate
of the CS, CS+DIAG, and FAM1 forms.
In simulations, the true breeding value is known, and the GEBV
calculated in the lines of the validation set can be compared to the true
breeding values to determine the predictive ability and the accuracy and
precision of the GEBV. As real data were used here, the true breeding
value was unknown. In the absence of pedigree information, the
genotypic values (GV) of the lines in the validation set were used as
the comparator. These were calculated from a phenotypic model, based
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n Table 2 Number of lines with marker information in the groups used in the cross-validation
Groups for
Cross-Validation
1–6
7–9
10
Total

Total Number of Lines in Each Group
(Total Number of Lines Across Groups)

Number of Linesa in Each Group
Commonb

2010 Only

2011 Only

2010

2011

METc

46
46
45
459

0
0
1
1

2
1
2
17

46 (276)
46 (138)
46 (46)
460

48 (288)
47 (141)
47 (47)
476

48 (288)
47 (141)
48 (48)
477

a
These are the number of lines with marker information.
b
The common lines groups are kept the same across all analyses.
c

The multi-environment trial (MET) analyses contain information from both trial years.

on all the lines with marker information, where lines were assumed to be
unrelated. The GVs from this phenotypic model reﬂect total genetic
effects, and were calculated using single trial and MET analyses. In
crops, breeders are most often interested in the commercial potential
of lines, so the adoption of the genotypic values (which are the total
genetic values of each line) as the comparator to GEBV of validation
lines reﬂects this crop breeding strategy. Linear regression models were
ﬁtted in which the response was the observed GVs of lines in the validation set, and the explanatory variable was the GEBVs of those same
lines calculated using the marker effects. The cross-validation investigated the performances of the partitioned and standard RR-BLUP models in terms of their predictive ability measured by the R-squared value,
and the accuracy and precision of the GEBV measured by the mean
square error (MSE) from the linear regression models. The standard and
phenotypic models were compared using the same training sets.
Comparisons were investigated between the GEBVs and GVs, where the
same model (single trial or MET) and marker terms were used to derive both
the GEBV and GV. A further comparison was made between the GEBVs of
the main effect from the MET model to GVs from a single trial analysis of
each trial year. The R script for performing each cross-validation (CV10,
CV20,andCV40)undereachscenario(singletrial2010,singletrial2011,and
MET) can be found in File S6, File S7, File S8, File S9, File S10, and File S11.
Implementing GS with a lower density of markers
In addition to using all the markers to predict the GEBV of lines in the
validation set, we explored a low-density GS approach, where a subset of
random, rather than signiﬁcant, markers and their effects were used to
predict the GEBV of lines. This was explored for CV10 only (Table 2).
For each of the 10 training sets of lines, subsets of markers of
increasing size, x, from x = 10 to x = 3490 (all markers) were chosen
at random. For each size x, and each training set of lines, the markers
were chosen at random, and resampled to provide 200 different random combinations of size x. The performance at each subset of
markers was measured as the average of the regression coefﬁcients,
and mean square error over the 200 random combinations of size x.
For each x, each scenario and model was compared using the same
random marker subsets and the same training set of lines. R scripts can
be found in File S12, File S13, File S14, File S15, File S16, and File S17.
Data availability
All data necessary for conﬁrming the conclusions presented in this
manuscript are provided in Supplemental Material.
RESULTS
Height phenotypic data in multi-environment trials
An association mapping population of two-row spring barley lines was
grown in a randomized spatial row-column design in two consecutive

1318 |

H. Oakey et al.

trials in years 2010 and 2011 (i.e., two environments), with ﬁve replicate
plants of each line. At full maturity, the height of each plant was
measured. The raw mean heights for lines grown in both years, and
for which we have marker information, are shown in Figure 1. The
plant height was slightly elevated in 2010 as opposed to 2011; the mean
height in 2010 was 94.8 cm, and in 2011 was 87.9 cm. The correlation
between the means of the line heights across the years was high at 0.76.
These data were subsequently used, as described below, to develop our
new GS model, and to predict, based only on the complement of lines
with molecular markers present in each training set, the GEBV for
height of lines that were in each validation set.
Comparison of models for whole genome prediction
Initially, the partitioned, standard, and phenotypic models were ﬁtted
(Table 4) using the full data set, enabling the form of um (Table 1), the
term representing marker variation, and ue , the term representing nonadditive or residual genetic variance, to be established for use in the
cross-validation. All models included a random term for replicate block
for both trials; an additional random term was also included in the
analysis to account for spatial variation present between columns in
2011.
Log-likelihood ratio tests comparing standard and partitioned
models with the same form of um (e.g., SDIAG vs. PDIAG, SCS+DIAG vs.
PCS+DIAG, etc.) were signiﬁcant (P , 0.001), suggesting the partitioned
models are superior to the standard models (Table 4). In addition, all
the MET models had lower AIC than the single trial year models,
suggesting that the MET models were superior (Table 4). For two trials,
the factor analytic models (EFAM1, SFAM1, and PFAM1), and the unstructured models (EUS, SUS, and PUS), respectively, are identical, and therefore the US results are shown with the FAM1 model in Table 4. Given
that the factor analytic model has been shown previously to improve
the predictive accuracy of the line empirical BLUPs, that factor analytic
models are easier to ﬁt than an unstructured model (Kelly et al. 2007),
and given that we are primarily interested in models that ﬁt a main
marker term, the US model is not discussed further.
For the phenotypic, standard, and partitioned MET models, the
compound symmetry form (ECS, SCS and PCS) had the highest AIC,
suggesting that this model was not a good choice in comparison to the
other forms. The CS+DIAG forms (ECS+DIAG and PCS+DIAG) had similar
AICs to the factor analytic models (EFAM1 and PFAM1). However, the
factor analytic model of the standard model (SFAM1) showed a lower
AIC than the CS+DIAG form (SCS+DIAG). Examining the REML
estimates of the variance components (Table 5), it is clear that the
CS+DIAG model does not necessarily ﬁt as well as the FAM1 model, as
the covariance between years has been constrained to be equal to the
2011 trial variance. However, as the variance component estimates of
the CS+DIAG form (ECS+DIAG, SCS+DIAG, and PCS+DIAG) and the
FAM1 form (EFAM1, SFAM1, and PFAM1) were similar for this data

n Table 3 Summary of validation and training groups in three cross-validations
Cross-Validation
CV10
CV20
CV40

Number of Groups in
VALIDATION Set
1
2
4

Numbera (%) of Line Numbers in the VALIDATION Set
2010
46 (10)
92 (20)
184 (40)

2011
47 (9.7) – 48 (10.1)
94 (19.7) – 96 (20.2)
188 (39.5) – 192 (40.3)

MET (both years)
47 (9.9) – 48 (10.1)
94 (19.7) – 96 (20.1)
188 (39.4) – 192 (40.3)

Number of Groups Total Numberb
in TRAINING Set
of Iterations
9
8
6

10
45
210

a
The number will be a range for 2011 and the MET as the number of lines in each group (Table 2) is variable.
b

This is the number of iterations so all combinations of groups in the validation set can be investigated.

despite these constraints, both these forms were investigated further
in the cross-validation. It is worth noting that Table 4 does not show
the complete set of possible partitioned models. For the partitioned
model, we have explored only models with the same form for the um
and ue terms. It is, however, possible to include different forms for
each of um and ue terms, for example, the former could take a compound symmetry form, and the latter a factor analytic form. When
ﬁtting the FAM1 model, the full parameterization required ﬁve parameters (one for the main effect, two loadings, and two speciﬁc
variances), two more than the three required. Thus, when ﬁtting
the FAM1 model, the two speciﬁc variances were constrained to be
zero. Smith et al. (2001) discuss the parameter constraints necessary
for FAk models with k . 1. Thus based on the results of the loglikelihood ratio tests, AIC, and estimates of the model variance components, for the MET analysis of trials in the cross-validation, we
explore only the CS+DIAG and FAM1 forms for the marker and
residual genetic effects. From the variance components of the diagonal form of the phenotypic model, the heritability of the trials was
calculated as 0.90 in 2010 and 0.75 in 2011, so both trials have high
heritability. The difference in heritability between years reﬂects a
greater contribution of environment to the variation in 2011, and
consequently a lower proportion of variation that is genetic in that
year. A comparison between the variance of the ue term from phenotypic and the partitioned DIAG models (EDIAG and PDIAG, respectively) enabled an estimate of the proportion of genetic variation
accounted for by the markers, which was 0.75 for trial 2010, and
0.73 for trial 2011. The R code for determining the proportion of
genetic variation is in File S19.
The variance components of the residual terms in each year were higher
in the standard models compared to the equivalent forms of the phenotypic
and partitioned models, particularly in 2011. The total genetic variation is
therefore not accounted for in this model, perhaps as expected, given that
the marker effect should reﬂect just additive genetic variation; the proportion of the genetic variation not being accounted for by the markers
thus has contributed to the enlarged residual term. Given these limitations,
the standard models were not taken forward for cross-validation.
Cross-validation of selected models
The lines were randomly divided into 10 equivalent groups to facilitate
comparative cross-validations, where the majority of lines were used as
the training set, while 10%, 20%, or 40% of lines constituted the CV10,
CV20, and CV40 validation sets, respectively (see Materials and Methods and Table 3).
The cross-validation focuses on comparing the partitioned and the
standard RR-BLUP model in each of three scenarios, which are each
trial year separately (PDIAG and SDIAG, respectively), and in a joint MET
analysis of both years. From the initial ﬁtting of the MET models just
discussed, we examine only the models where the form of um and ue
takes either CS+DIAG (PCS+DIAG and SCS+DIAG, respectively), or FAM1
(PFAM1 and SFAM1, respectively). When ﬁtting the standard and

partitioned models of the factor analytic form (SFAM1, PFAM1) in
ASReml, speciﬁc variances were set to zero as in the full data set,
and the variance components of SFAM1 were used as starting values
for the variance components of PFAM1.
Various comparisons between the predicted (GEBVs) and observed
(GVs) results were made, and the performance of the partitioned and
standard RR-BLUP models in terms of predictive ability of the markers
was measured by the R-squared value (Table 6), while the accuracy of
line estimates (GEBVs) was measured by the mean square error (Table 7).
Both of these were averages across the iterations (Table 3).
In all three different CV evaluations [CV10, CV20, and CV40 (Table 3)],
the partitioned model showed a higher R-squared and lower MSE
than the standard model, indicating that the predictive ability and
accuracy of line estimates (GEBVs) were superior in the partitioned
model. This supports the ﬁnding of lower log-likelihoods and superior
ﬁt of the partitioned models as compared to the standard models when
the full data were used (Table 4). The R-squared decreased, and the
MSE increased, as the number of lines in the training set decreases
(going from CV10 to CV40) for the equivalent model (i.e., within the
partitioned models, or within the standard models), which was
expected, as predictions were based on fewer lines. It should be noted
that, except where the 2011 marker effects from the PDIAG model were
used to generate the GEBVs (Comparisons 2 and 3, Table 6), the
R-squared in the partitioned model in CV40 (where 40% of the lines
were in the validation set) was similar to, or higher than, the R-squared
of the standard model in CV10 (where 10% of the lines are in the
validation set), suggesting the partitioned model was superior even
when reducing the number of lines upon which the predictions are
based. There was only a small compensating increase in MSE between
the standard model in CV10, and the partitioned model in CV40, with
the same exception of the 2011 marker effects from the PDIAG model
(Comparisons 2 and 3, Table 7), and also the main marker effects from
the PFAM1, which showed larger increases (Comparison 12, Table 7).
These results shows that the partitioned model provides the best
predictions of the height of lines in the validation set.
The results of the CV10 cross-validation were considered in more
detail, bearing in mind that the other cross-validations (CV20 and
CV40) reﬂect similar patterns. Initially, results where the equivalent of a
single trial analyses was used to generate both GEBVs (PDIAG and SDIAG)
and GVs (EDIAG) were examined. Using the same trial year to generate
both the GEBVs and GVs (Comparisons 1 and 3, Table 6) gave the best
results. The single trial analysis from 2010 showed a higher predictive
ability than that from 2011 for the partitioned model (0.461 vs. 0.334,
Table 6), and for the standard model (0.404 vs. 0.323, Table 6). This
difference between the predictive ability in each year was initially surprising; given that there was a large overlap of individuals, the percentage of variation explained by the markers was similar, and the
observations were highly correlated across the 2 years. The partitioned
model showed a 5.7% and 1.1% improvement for 2010 and 2011, respectively, in predictive ability over the standard model.
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suggested that the environment had a large inﬂuence on the results. The
greater environmental inﬂuence in 2011 is consistent with the lower
heritability and reduced genetic inﬂuence on plant height compared to
the 2010 trial (see previous section). Greater environmental stress may
also explain the lower mean height of lines in 2011.
Finally, we compared the GEBVS derived from the main marker
effects in a MET analysis with the GVs derived from the single year
analysis. Again the CS+DIAG form was superior to the FAM1 form for
um in terms of predictive ability, and we therefore concentrated on the
former (Comparisons 9 and 10, Table 6). There was a reduction in
predictive ability if the year speciﬁc marker effect was omitted when
calculating the GEBVs, particularly for 2011 (0.448 vs. 0.336, Comparison 6 and 10, Table 6), where the environmental inﬂuence was higher.
However, despite this reduction, a similar predictive ability to a single
trial analysis was maintained, and the main effect still had a higher
predictive ability than using the marker effects from the opposite year.
For example, it is 3.5% higher in 2010 (Comparisons 9 and 2, 0.442 vs.
0.407), and 1.7% higher in 2011 (Comparisons 10 and 3, 0.336 vs.
0.319), with correspondingly lower MSE.
Figure 1 Correlation of mean heights of lines in the 2010 and 2011
trials. The datapoints represent only the lines with marker data that
were grown in both years.

If the opposite trial years were used to generate the GEBVs, then
predicting 2010 GVs using the marker effects generated in 2011
(Comparisons 2, Table 6) had a higher predictive ability than the opposite combination (Comparisons 4, Table 6), for both the partitioned
and standard models. Ly et al. (2013) suggested that G · E, which
cannot be accounted for in a single trial, reduces the ability to make
predictions. These results suggest that the 2011 heights had a higher
environmental component than those observed in 2010, making prediction of the GEBVs from 2011 more difﬁcult. We would therefore
expect to be able to predict trial year 2011 better if a marker by trial
interaction effect was included in a MET model, and this is exactly what
was found, as discussed below.
The next comparisons are the MET analyses, where the GEBVs and
GVs are based on a total effect found by summing the main or overall
marker effect and the trial year marker effects. The ﬁrst thing to note is
that for 2010 the CS+DIAG form for um had around a 4–6% higher
predictive ability than the FAM1 form in both the standard and partitioned models (Comparisons 5 and 7, Table 6). For 2011, the results
were similar between the forms of um (Comparisons 6 and 8, Table 6),
with around a 0.1% difference in predictive ability between the FAM1
form and the CS+DIAG form, with the latter showing only a slightly
lower predictive ability, but a lower MSE. This suggests that the
CS+DIAG form was superior to the FAM1 form for this data set.
Exploring different forms for um is clearly an important step in
determining the best model for GS.
The results for predictive ability were similar between the MET
analysis and single year analysis for 2010 (Comparisons 5 and 1, 0.462
v 0.461, partitioned model, Table 6), but the MET shows a lower MSE
(Comparisons 5 and 1, 7.35 v 7.47, partitioned model, Table 7). For
2011, the results of the MET were clearly superior over the single year
analysis (Comparisons 6 and 3, Table 6), at 11.4% higher (0.448 v
0.334) for the partitioned model and 7.2% (0.395 v 0.323) for the
standard model. This suggests that using 2 years’ data greatly improved
the accuracy of the GEBVs by up to 11.4% for this data set. The beneﬁt
of including the marker by trial interaction effect was apparent in 2011
in particular, the year in which the results from the single trial analysis
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Implementing GS with a lower density of markers
A low density GS approach was considered, where, for each of the
training sets of lines in CV10, the predictive ability of subsets of random
markers was investigated. The results of the MET analyses and single
trial analyses across the subsets of random markers were compared in
each trial year (Figure 2 and Figure 3 for trial 2010 and trial 2011,
respectively). Both plots showed that the partitioned models have a
much steeper incline within the subsets of random markers containing
less than 500 markers than the standard models, with the graphs ﬂattening out more than the standard models as the marker numbers in
subsets increase. This suggests that, for lower numbers of markers, the
predictions were more accurate and reliable in the partitioned model,
and therefore fewer markers were required to obtain similar predictions. This would tend to support the ﬁnding that the line estimates
based on markers from the partitioned model were more accurate
(lower MSE, Table 7) than those of the standard model. The horizontal
lines in Figure 2 and Figure 3 show the single trial year analysis of the
standard model using data from the same year. For trial 2010, all of the
partitioned models had superior predictive ability across the entire
range of marker subsets (Figure 2), with the main improvements in
predictive ability coming within the ﬁrst 1000 or so markers. In the
standard RR-BLUP model, although there was an initial improvement
in the predictive ability, this was less intense, and mostly small and
steady over all of the latter marker subsets. This means that we can
achieve the same predictive ability with the MET model as with the
standard RR-BLUP model using around 1000 markers, or around 2490
markers less than in the full higher-density GS. In 2011, the partitioned
models had superior performance over the standard single year model
for lower numbers of markers, with the partitioned MET model reaching the same level of prediction with only 500 markers.
DISCUSSION
In this paper, a method for genomic selection is proposed for the
analysis of multi-environment crop trials. The method differs from
other methods in a number of ways.
The method uses raw data observations at the plot, or pot, level rather
than line means, thus incorporating line replication. This enables the
total genetic variation due to lines to be partitioned into variation due to
markers, and residual genetic variation, where the latter accounts for any
genetic variation unexplained by the markers. The GEBVs, which are
based on marker effects, are assumed mostly to reﬂect additive effects.

n Table 4 Summary of the models ﬁtted to the full data set
Formb of um

Modela
Phenotypicc

Standardi

Partitioned j

EDIAG
ECS
ECS+DIAG
EFAM1, EUS
SDIAG
SCS
SCS+DIAG
SFAM1, SUS
PDIAG
PCS
PCS+DIAG
PFAM1, PUS

Form of ue
DIAGd
CSe
CS+DIAGf
FAM1g, USh

DIAG
CS
CS+DIAG
FAM1, US
DIAG
CS
CS+DIAG
FAM1, US

DIAG
CS
CS+DIAG
FAM1, US

STY or MET

Log-Likelihood

AIC

STY
MET
MET
MET
STY
MET
MET
MET
STY
MET
MET
MET

211,074.6
210,877.0
210,872.5
210,872.4
210,924.9
210,794.0
210,790.6
210,787.8
210,876.4
210,747.2
210,744.6
210,744.2

22,163.1
21,768.1
21,760.9
21,760.8
21,863.8
21,602.1
21,597.2
21,591.6
21,770.8
21,512.5
21,511.2
21,510.4

STY, single trial year; MET, multi-environment trial; AIC, Akaike information criteria.
a
All models derive from Equation 1 but are special cases of g (Equation 2).
b
Details of forms of um are given in Table 1.
c
Phenotypic model has g = ue.
d
DIAG implies the covariance between the two trials is assumed to be zero, and is equivalent to ﬁtting the two trials separately.
e
CS is the compound symmetry model.
f
CS+DIAG is the model described by Cullis et al. 1998.
g
FAM1 is the factor analytic model (Smith et al. 2001), with main effect with k the number of factors equal to 1.
h
US is the unstructured model (US), for two trials this model is equivalent to the FAM1 model.
i
Standard RR-BLUP model has g ¼ ðIs 5MÞum.
j
Partitioned RR-BLUP model has g ¼ ðIs 5MÞum + ue.

The residual genetic effect therefore should capture nonadditive effects.
In inbred lines, the nonadditive effect will represent epistatic effects.
However, in noninbred lines, other nonadditive effects will include
dominance, inbreeding depression and homozygous dominance effects,
the covariance between additive and dominance effects, and epistatic
effects (de Boer and Hoeschele 1993).
Previous studies (Solberg et al. 2009; Crossa et al. 2010; Burgueno
et al. 2012) have included pedigree information, which captures a polygenic effect as a way of accounting for nonadditive effects, and more
recent studies (Da et al. 2014; Munoz et al. 2014) have used markerbased relationships to separate additive and nonadditive variation. Da
et al. (2014) only included additive and dominance relationship matrices. Munoz et al. (2014) included, in addition, ﬁrst-order epistatic relationship matrices (additive by additive, dominance by dominance,
and additive by dominance); however, their approach has the disadvantage that the resulting genetic effects are nonorthogonal, and there is
dependency between some of the estimates of the additive and nonadditive variance components, as the ﬁrst-order epistatic relationship
matrices they form are based on Hadamard products of the additive
and dominance relationship matrices. This means that the matrices
may not be capturing all nonadditive variation. Also, given the number
of relationship matrices necessary to account for nonadditive variation,
extension to a MET model may be difﬁcult. In contrast, the residual
genetic effect representing nonadditive effects found in our model is
more encompassing and less restrictive, and should capture all nonadditive effects. It is, however, worth noting that, because of the ﬂexibility of the linear mixed model, additional relationships matrices
may also be added to our model if required. For example, if pedigree
information was available, a single polygenic effect could be added, or
it may be possible to further partition our residual genetic effects by the
addition of further genomic relationship matrices, for instance, a genomic dominance matrix could be added in the case of hybrid crops.
Recent studies have shown that maximum prediction was reached
when the breeding value was based on both additive and nonadditive
effects (Da et al. 2014; Munoz et al. 2014), and Ly et al. (2013) notes that
considering only the additive component may underestimate prediction accuracy. Here, we have only investigated the use of the additive

proportion of the total genetic effect as described by the markers for the
prediction of breeding values where, for future lines, only marker information is available. We found that partitioning the total genetic
variation into marker and residual genetic variation, and using the
improved predictive ability of the marker additive genetic effects for
future predictions, gave more accurate estimates even for the single trial
analysis than was the case if the total genetic variation was not partitioned (i.e., when ﬁtting the standard model, which excluded the residual genetic and therefore nonadditive, variation). Improvements of
up to 5.7% in predictive ability were found. Further work is required to
determine whether improved prediction can be achieved by using the
total genetic effect (as opposed to the total genetic effect from markers)
of a line from the partitioned model for phenotypic evaluation. The
value of using the total genetic effect (additive plus nonadditive) for
phenotypic evaluation would depend on the impact of the nonadditive
proportion. If the nonadditive proportion of variation was reasonably
high, the use of the total genetic effect for phenotypic evaluation would
be important. However, it is worth noting the total genetic effect does
not reﬂect the potential of a line as a parent as nonadditive effects are
not inherited, although it may better predict the commercial viability of
a line and may be useful in determining which lines to take forward
from a breeding program for elite development.
Using the raw data in a single stage approach has the added advantage
that it allows spatial variation to be incorporated into the analysis,
enabling joint estimation of all effects, genetic and nongenetic. This is
the preferred option, as the precorrection of data necessary in a two
stage approach can have undesirable consequences, such as biased
estimates of marker effects, and induced correlations between residuals
(de los Campos et al. 2013).
It was evident from the analysis that the standard model had an
inﬂated trial residual (error) term compared to the partitioned model.
The partitioned model enabled the additive variation due to markers to
be estimated, and it was found to account for approximately 75% of the
total genetic variation in each of the trials. In the standard model, the
inﬂation of the trial residual term, while apparent, was not sufﬁcient to
explain all of the unaccounted nonadditive genetic variation. This
suggests that, in the standard model, some of the omitted nonadditive
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95.41
93.73
94.95
95.29
101.26
97.99
98.09
99.83
95.73
94.11
95.51
95.48
39.23
39.37
39.23
39.23
40.72
41.23
41.01
40.76
39.24
39.35
39.23
39.23
0
19.97
19.54
19.35

0
92.77
89.45
89.59

27.67
27.04
28.84
27.86

23.43
27.04
22.03
23.46

86.35
103.22
89.45
88.18

0.0365
0.0659
0.0595
0.0519
0.0194
0.0240
0.0218
0.0205
0.0703
0.0659
0.0670
0.0718
0.0265
0.0240
0.0246
0.0260
DIAG
CS
CS+DIAG
FAM1, US

STY
MET
MET
MET
STY
MET
MET
MET
STY
MET
MET
MET
DIAG
CS
CS+DIAG
FAM1, US

DIAG
CS
CS+DIAG
FAM1, USc
DIAG
CS
CS+DIAG
FAM1, US
Partitioned

Standard

EDIAG
ECS
ECS+DIAG
EFAM1, EUS
SDIAG
SCS
SCS+DIAG
SFAM1, SUS
PDIAG
PCS
PCS+DIAG
PFAM1, PUS
Phenotypic

H. Oakey et al.

STY, single trial year; MET, multi-environment trial, Covar, covariance between trial year 2010 and trial year 2011.
a
All models derive from Equation 1 but are special cases of g (Equation 2).
b
Details of forms of um are given in Table 1 and Table 4.
c
For two trials the US model is equivalent to the FAM1 model.

0
0.0626
0.0595
0.0584
0
0.0227
0.0218
0.0221

111.65
103.22
109.05
109.99

Year 2011

Residual Rt

Year 2010
Covar
Year 2011

var(ue)

Year 2010
Covar
var(um)

Year 2011
Year 2010
STY or MET
Form of ue
Formb of um
Modela

n Table 5 REML estimates of variance components of the models ﬁtted (Table 4)

1322 |

genetic variation is incorporated into the estimate of the genetic variation due to the markers, and they do not therefore reﬂect purely
additive variation. This perhaps explains why, in the standard model,
the marker effects are not as good for prediction of GEBVs, and this
model showed higher MSE of prediction. The outcome is that estimates of marker effects from the partitioned model should be less
biased, be more likely to reﬂect additive variation, and therefore lead
to better estimation for future prediction.
The single trial RR-BLUP partitioned model was extended to enable
a multi-environment approach to analysis. Analyzing trials under the
partitioned RR-BLUP model in a MET setting extends a phenotypic
MET model in an intuitive manner. In the GS model, we implicitly
included both a main effect for markers, and a marker by trial interaction term. We found that a main marker effect in an analysis of trials
in a MET was a useful predictor, even when a strong marker by trial
interaction was present. These main marker effects seem to reﬂect a
more ‘stable’ proportion of the marker, and were shown to have a
predictive ability slightly superior to a single trial analysis. Presumably,
the addition of more trials would improve the robustness of the main
marker effect to G · E.
The RR-MET (partitioned and standard) performed well particularly where there was a larger environmental inﬂuence. In the example
data set, in the 2011 trial, improvements of the MET over the single trial
analysis of as much as 11.4% were seen, probably due to the inability of
a single year analysis to account for the marker by trial variation. The
poorer performance found when using 2011 marker effects to predict
2010 supports the observation of Ly et al. (2013) that the presence of
G · E reduces the ability to make predictions in locations where no
evaluations have previously been done. MET analysis uses the correlation between trials to improve prediction of lines (Smith et al. 2005).
Where the environmental inﬂuence was lower, as in the 2010 trial, the
partitioned single trial model performed well, with similar predictive
ability to the partitioned MET model, but with lower MSE in the latter.
As in Guo et al. (2013), gains here are attributable to the more accurate
estimates of trial-speciﬁc marker effects through utilizing genetic correlations. In our cross-validation approach, we excluded validation
lines from both trials, and found that, in 2011, where environmental
inﬂuence was large, the MET was superior to the single trial analysis.
Burgueno et al. (2012) and Guo et al. (2013) also looked at MET verses
single trial analysis and included cross-validation schemes (referred to
as CV1 in both papers), which also excluded validation lines from all
environments. Our ﬁndings are contrary to those of Burgueno et al.
(2012), who found no improvement in predictability of a MET over a
single trial analysis, but support the ﬁndings of Guo et al. (2013), who
found similar average gains in prediction accuracies of up to 10%.
In terms of using a subset of the markers in a low density GS
approach, similar predictive ability could be gained with a much lower
number of markers in the partitioned MET model, particularly in 2011.
The results suggest that the partitioned model increased the accuracy of
the marker effects with further gains to be had by using the MET model,
particularly if the environmental inﬂuence on results is high (as in
2011). When examining the value of predictive ability of random subsets of markers, some subsets were superior to others (results not
shown). Examining markers that are consistently found in the highly
predictive subsets may lead to suitable choices for a MARS approach,
and this may be worth exploring when considering the practical and
optimal use of markers in GS in crops. Finally, as Heffner et al. (2011a,
2011b) have found, reducing the number of lines in a training population decreases the predictive ability. However, our observations suggest that the partitioned model goes some way to alleviating this effect.
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EDIAG
EDIAG
EDIAG
EDIAG
ECS+DIAG
ECS+DIAG
EFAM1
EFAM1
EDIAG
EDIAG
EDIAG
EDIAG
2010
2010
2011
2011
Total 2010
Total 2011
Total 2010
Total 2011
2010
2011
2010
2011

Line Effects to
Generate GVb
SDIAG
SDIAG
SDIAG
SDIAG
SCS+DIAG
SCS+DIAG
SFAM1
SFAM1
SCS+DIAG
SCS+DIAG
SFAM1
SFAM1

Standard
Model
PDIAG
PDIAG
PDIAG
PDIAG
PCS+DIAG
PCS+DIAG
PFAM1
PFAM1
PCS+DIAG
PCS+DIAG
PFAM1
PFAM1

Partitioned
Model
2010
2011
2011
2010
Total 2010
Total 2011
Total 2010
Total 2011
Main
Main
Main
Main

Markerc Effects to
Generate GEBV
0.406(0.048)
0.359(0.062)
0.298(0.046)
0.288(0.043)
0.410(0.046)
0.401(0.043)
0.376(0.051)
0.402(0.048)
0.392(0.056)
0.302(0.040)
0.377(0.063)
0.299(0.040)

Partitioned
Model

CV40

0.366(0.047)
0.333(0.055)
0.280(0.043)
0.252(0.050)
0.368(0.044)
0.360(0.041)
0.320(0.044)
0.365(0.043)
0.350(0.048)
0.271(0.040)
0.323(0.059)
0.268(0.039)

Standard
Model

0.438(0.064)
0.383(0.095)
0.318(0.081)
0.307(0.060)
0.439(0.061)
0.428(0.062)
0.403(0.071)
0.430(0.056)
0.419(0.082)
0.322(0.068)
0.404(0.092)
0.323(0.070)

Partitioned
Model

CV20

0.390(0.055)
0.362(0.091)
0.304(0.081)
0.267(0.070)
0.392(0.049)
0.382(0.053)
0.335(0.059)
0.386(0.052)
0.371(0.068)
0.289(0.066)
0.336(0.087)
0.287(0.070)

Standard
Model

0.461(0.093)
0.407(0.137)
0.334(0.138)
0.319(0.097)
0.462(0.088)
0.448(0.098)
0.423(0.097)
0.448(0.083)
0.442(0.115)
0.336(0.115)
0.430(0.125)
0.338(0.118)

Partitioned
Model

CV10

0.404(0.085)
0.387(0.139)
0.323(0.144)
0.277(0.122)
0.406(0.078)
0.395(0.089)
0.344(0.093)
0.396(0.085)
0.387(0.101)
0.300(0.117)
0.349(0.122)
0.302(0.128)

Standard
Model

GEBV, genomic estimated breeding value; GV, genotypic value SD¼standard deviation.
a
The R-squared value is from a linear model for the validation set in which the GEBV is the covariate and the GV the response, the R-squared value shown is the average of the R-squared value over the different
iterations (Table 2). Large R-squared values indicate better predictive ability.
b
GV are calculated using a phenotypic model with all of the lines.
c
Marker effects from DIAG form are in bold with year of trial shown, and are equivalent to results from a single trial year analysis, marker effects for the MET analyses are in bold and italic, three marker effects are
possible: main, interaction 2010, interaction 2011; with the sum of the (main + interaction) marker effects being equivalent of a total marker effect for a particular year.

1
2
3
4
5
6
7
8
9
10
11
12

Comparison

Phenotypic
Model

R-Squared (SD)

n Table 6 Average R-squareda (SD) of partitioned verses standard RR-BLUP model for different cross-validation (Table 3), models (Table 4) and effects used to generate the GV and
GEBV
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EDIAG
EDIAG
EDIAG
EDIAG
ECS+DIAG
ECS+DIAG
EFAM1
EFAM1
EDIAG
EDIAG
EDIAG
EDIAG

Standard
Model
SDIAG
SDIAG
SDIAG
SDIAG
SCS+DIAG
SCS+DIAG
SFAM1
SFAM1
SCS+DIAG
SCS+DIAG
SFAM1
SFAM1

Line Effects to
Generate GVb
2010
2010
2011
2011
Total 2010
Total 2011
Total 2010
Total 2011
2010
2011
2010
2011

PDIAG
PDIAG
PDIAG
PDIAG
PCS+DIAG
PCS+DIAG
PFAM1
PFAM1
PCS+DIAG
PCS+DIAG
PFAM1
PFAM1

Partitioned
Model
2010
2011
2011
2010
Total 2010
Total 2011
Total 2010
Total 2011
Main
Main
Main
Main

Marker Effects to
Generate GEBVc
7.86(0.72)
8.10(0.54)
6.77(0.39)
6.89(0.49)
7.74(0.70)
6.79(0.55)
9.55(0.83)
6.81(0.61)
7.79(0.61)
6.73(0.41)
7.88(0.57)
6.74(0.40)

Partitioned
Model

CV40

8.13(0.74)
8.27(0.55)
6.85(0.40)
7.06(0.51)
8.01(0.75)
7.02(0.57)
9.98(0.87)
7.02(0.62)
8.06(0.63)
6.87(0.42)
8.21(0.55)
6.89(0.40)

Standard
Model

7.64(1.09)
7.91(0.78)
6.65(0.59)
6.80(0.71)
7.53(1.04)
6.61(0.75)
9.34(1.34)
6.63(0.83)
7.58(0.88)
6.62(0.60)
7.66(0.85)
6.61(0.59)

Partitioned
Model

CV20

7.96(1.09)
8.04(0.77)
6.72(0.60)
6.98(0.73)
7.85(1.09)
6.88(0.77)
9.87(1.39)
6.88(0.87)
7.89(0.87)
6.78(0.59)
8.09(0.77)
6.78(0.57)

Standard
Model

7.47(1.57)
7.70(1.08)
6.52(0.89)
6.72(1.01)
7.35(1.49)
6.44(1.01)
9.19(1.96)
6.49(1.13)
7.38(1.18)
6.52(0.86)
7.45(1.15)
6.50(0.85)

Partitioned
Model

CV10

7.85(1.59)
7.82(1.05)
6.57(0.90)
6.92(1.09)
7.73(1.55)
6.75(1.02)
9.80(2.07)
6.79(1.22)
7.75(1.17)
6.69(0.85)
7.94(1.00)
6.66(0.81)

Standard
Model

GEBV, genomic estimated breeding value; GV, genotypic value; SD¼standard deviation.
a
The mean square error value is from a linear model for the validation set, in which the GEBV is the covariate and the GV the response. The mean square error shown is the average of the mean square error over the
different number of iterations (Table 2). Lower mean square error indicates more accurate and precise estimates of GEBV.
b
GV are calculated using a phenotypic model with all of the lines.
c
Marker effects from DIAG form are in bold with year of trial shown, and are equivalent to results from a single trial year analysis, marker effects for the MET analyses are in bold and italic, three marker effects are
possible: main, interaction 2010, interaction 2011, with the sum of the (main + interaction) marker effects being equivalent of a total marker effect for a particular year.

1
2
3
4
5
6
7
8
9
10
11
12

Comparison

Phenotypic
Model

Mean Square
Error (SD)

n Table 7 Average mean square errora (SD) of partitioned verses standard RR-BLUP model for cross-validation (Table 3), models (Table 4) and effects used to generate the GV and
GEBV

Figure 2 Comparison of partitioned vs. standard RR-BLUP model of
CV10 (Table 3) for different forms (Table 1) and comparisons (Table 6)
for trial year 2010 across a range of subsets of random markers. The
horizontal line is maximum predictive ability of the standard single trial
year analysis for 2010. Each subset represents the average results from
200 different sets of random markers, the comparisons across analyses
are on the same subsets of random markers. MET, multi-environment
trial analysis; STY, single trial year analysis; part, partitioned model;
std, standard model; total, main marker effect + marker by trial interaction effect; main, main marker effect; same, same year used for
prediction (2010 GEBV used to predict 2010 GV); opp, opposite year
used for prediction (2011 GEBV used to predict 2010 GV); C, see
Comparison as per Table 6 for more detail.

In summary, the partitioned MET model used here is a single linear
mixed model that incorporates trial, residual genetic-by-trial interactions, and trial-speciﬁc ﬁeld and randomization-based terms, in a random RR-BLUP setting for marker effects and their interaction with
trials. The MET model offers a viable, ﬂexible addition to the GS tool
box.
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